Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,241,983 papers from all fields of science
Search
Sign In
Create Free Account
30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza]
Known as:
ACLIDINIUM BROMIDE 400 ug RESPIRATORY (INHALATION) INHALANT [Tudorza Pressair]_#1
, 30 ACTUAT Tudorza 0.4 MG/ACTUAT Dry Powder Inhaler
, Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Dry Powder Inhaler
Lactose Monohydrate
Tudorza
aclidinium
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Duaklir Pressair: another LAMA/LABA inhaler for COPD.
The Medical letter on drugs and therapeutics
2019
Corpus ID: 204034044
2019
2019
NEW DRUG APPROVALS Duaklir Pressair for COPD
2019
Corpus ID: 180261643
NEW DRUG APPROVALS Duaklir Pressair for COPD The FDA has approved aclidinium bromide/formoterol fumarate (Duaklir Pressair…
Expand
Review
2017
Review
2017
Umeclidinium (Incruse Ellipta) for COPD.
R. Durigan
,
Valerie Niedermier
American Family Physician
2017
Corpus ID: 8599476
Umeclidinium is a relatively safe medication with few systemic adverse effects. As with aclidinium (Tudorza Pressair…
Expand
2012
2012
Tudorza Pressair (Aclidinium bromide)
F. Staff
2012
Corpus ID: 70980216
New combination: FDA approved aclidinium bromide (Tudorza Pressair, Forest) for the long-term maintenance treatment of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required